Exagen (XGN) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $6.8 million.
- Exagen's Accumulated Depreciation & Amortization rose 2068.23% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 2068.23%. This contributed to the annual value of $6.0 million for FY2024, which is 421.22% up from last year.
- Latest data reveals that Exagen reported Accumulated Depreciation & Amortization of $6.8 million as of Q3 2025, which was up 2068.23% from $6.4 million recorded in Q2 2025.
- In the past 5 years, Exagen's Accumulated Depreciation & Amortization ranged from a high of $6.8 million in Q3 2025 and a low of $200000.0 during Q1 2021
- In the last 5 years, Exagen's Accumulated Depreciation & Amortization had a median value of $5.6 million in 2024 and averaged $4.4 million.
- Per our database at Business Quant, Exagen's Accumulated Depreciation & Amortization soared by 213600.0% in 2022 and then tumbled by 1367.56% in 2024.
- Over the past 5 years, Exagen's Accumulated Depreciation & Amortization (Quarter) stood at $900000.0 in 2021, then soared by 77.78% to $1.6 million in 2022, then skyrocketed by 260.56% to $5.8 million in 2023, then increased by 4.21% to $6.0 million in 2024, then rose by 12.39% to $6.8 million in 2025.
- Its Accumulated Depreciation & Amortization was $6.8 million in Q3 2025, compared to $6.4 million in Q2 2025 and $6.1 million in Q1 2025.